- Home
- PLBC vs LUNG Comparison
PLBC vs LUNG Comparison
Compare PLBC & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBC
- LUNG
- Stock Information
- Founded
- PLBC 1980
- LUNG 1995
- Country
- PLBC United States
- LUNG United States
- Employees
- PLBC N/A
- LUNG N/A
- Industry
- PLBC Finance Companies
- LUNG Industrial Specialties
- Sector
- PLBC Finance
- LUNG Health Care
- Exchange
- PLBC Nasdaq
- LUNG Nasdaq
- Market Cap
- PLBC 253.9M
- LUNG 256.3M
- IPO Year
- PLBC 2005
- LUNG 2020
- Fundamental
- Price
- PLBC $46.73
- LUNG $6.34
- Analyst Decision
- PLBC Buy
- LUNG Buy
- Analyst Count
- PLBC 2
- LUNG 6
- Target Price
- PLBC $54.50
- LUNG $11.92
- AVG Volume (30 Days)
- PLBC 11.8K
- LUNG 214.3K
- Earning Date
- PLBC 01-15-2025
- LUNG 02-19-2025
- Dividend Yield
- PLBC 2.25%
- LUNG N/A
- EPS Growth
- PLBC N/A
- LUNG N/A
- EPS
- PLBC 4.80
- LUNG N/A
- Revenue
- PLBC $81,275,000.00
- LUNG $79,302,000.00
- Revenue This Year
- PLBC N/A
- LUNG $22.26
- Revenue Next Year
- PLBC $15.50
- LUNG $18.72
- P/E Ratio
- PLBC $9.73
- LUNG N/A
- Revenue Growth
- PLBC 4.55
- LUNG 22.34
- 52 Week Low
- PLBC $32.50
- LUNG $5.46
- 52 Week High
- PLBC $51.33
- LUNG $14.84
- Technical
- Relative Strength Index (RSI)
- PLBC 52.15
- LUNG 41.35
- Support Level
- PLBC $45.14
- LUNG $6.24
- Resistance Level
- PLBC $47.08
- LUNG $7.27
- Average True Range (ATR)
- PLBC 1.46
- LUNG 0.39
- MACD
- PLBC 0.15
- LUNG -0.06
- Stochastic Oscillator
- PLBC 71.49
- LUNG 2.52
About PLBC Plumas Bancorp
Plumas Bancorp is a bank holding company that provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.